BRIVA-LIFE-A multicenter retrospective study of the long-term use of brivaracetam in clinical practice

Behavioural changes in patients with intellectual disability treated with brivaracetam

(2018) E. Andres et al.   ACTA NEUROLOGICA SCANDINAVICA

New-onset epilepsy in the elderly

(2018) Lily Chi Vu et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Use of brivaracetam in genetic generalized epilepsies and for acute, intravenous treatment of absence status epilepticus

(2018) Adam Strzelczyk et al.   EPILEPSIA

Brivaracetam in the Treatment of Patients with Epilepsy—First Clinical Experiences

(2018) Felix Zahnert et al.   Frontiers in Neurology

Tolerability, efficacy and retention rate of Brivaracetam in patients previously treated with Levetiracetam: A monocenter retrospective outcome analysis

(2018) Martin Hirsch et al.   SEIZURE-EUROPEAN JOURNAL OF EPILEPSY

Efficacy, Retention, and Tolerability of Brivaracetam in Patients With Epileptic Encephalopathies: A Multicenter Cohort Study From Germany

(2018) Laurent M. Willems et al.   Frontiers in Neurology

Brivaracetam does not modulate ionotropic channels activated by glutamate, γ-aminobutyric acid, and glycine in hippocampal neurons

(2017) Isabelle Niespodziany et al.   EPILEPSIA

Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology

(2017) Robert S. Fisher et al.   EPILEPSIA

Postmarketing experience with brivaracetam in the treatment of epilepsies: A multicenter cohort study from Germany

(2017) Isabel Steinig et al.   EPILEPSIA

Retention of perampanel in adults with pharmacoresistant epilepsy at a single tertiary care center

(2017) Tim Wehner et al.   EPILEPSY & BEHAVIOR

Tolerability of new antiepileptic drugs: a network meta-analysis

(2017) Gaetano Zaccara et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Euro-Esli: a European audit of real-world use of eslicarbazepine acetate as a treatment for partial-onset seizures

(2017) Vicente Villanueva et al.   JOURNAL OF NEUROLOGY

Real-life experience with brivaracetam in 101 patients with difficult-to-treat epilepsy—A monocenter survey

(2017) Bernhard J. Steinhoff et al.   SEIZURE-EUROPEAN JOURNAL OF EPILEPSY

EARLY-ESLI study: Long-term experience with eslicarbazepine acetate after first monotherapy failure

(2016) V. Villanueva et al.   ACTA NEUROLOGICA SCANDINAVICA

Evidence for a differential interaction of brivaracetam and levetiracetam with the synaptic vesicle 2A protein

(2016) Martyn D. Wood et al.   EPILEPSIA

Efficacy and safety of brivaracetam for partial-onset seizures in 3 pooled clinical studies

(2016) Elinor Ben-Menachem et al.   NEUROLOGY

Efforts in Epilepsy Prevention in the Last 40 Years

(2016) Matti Sillanpää et al.   JAMA Neurology

A noninterventional study evaluating the effectiveness and safety of lacosamide added to monotherapy in patients with epilepsy with partial-onset seizures in daily clinical practice: The VITOBA study

(2015) Uwe Runge et al.   EPILEPSIA

A randomized, double-blind, placebo-controlled, multicenter, parallel-group study to evaluate the efficacy and safety of adjunctive brivaracetam in adult patients with uncontrolled partial-onset seizures

(2015) Pavel Klein et al.   EPILEPSIA

An open-label, prospective, exploratory study of patients with epilepsy switching from levetiracetam to brivaracetam

(2015) Stephen L. Yates et al.   EPILEPSY & BEHAVIOR

Antiepileptic drugs and adverse skin reactions: An update

(2015) Barbara Błaszczyk et al.   Pharmacological Reports

Injuries from seizures are a serious, persistent problem in childhood onset epilepsy: A population-based study

(2015) Carol Camfield et al.   SEIZURE-EUROPEAN JOURNAL OF EPILEPSY

The consequences of refractory epilepsy and its treatment

(2014) Kenneth D. Laxer et al.   EPILEPSY & BEHAVIOR

Effectiveness of Antiepileptic Drug Combination Therapy for Partial-Onset Seizures Based on Mechanisms of Action

(2014) Jay M. Margolis et al.   JAMA Neurology

Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: A phase III randomized, double-blind, placebo-controlled trial

(2013) Victor Biton et al.   EPILEPSIA

Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: Results from a double-blind, randomized, placebo-controlled trial

(2013) Philippe Ryvlin et al.   EPILEPSIA

Rational polytherapy with lacosamide in clinical practice: Results of a Spanish cohort analysis RELACOVA

(2012) Vicente Villanueva et al.   EPILEPSY & BEHAVIOR

Binding characteristics of brivaracetam, a selective, high affinity SV2A ligand in rat, mouse and human brain: Relationship to anti-convulsant properties

(2011) Michel Gillard et al.   EUROPEAN JOURNAL OF PHARMACOLOGY